Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT04303156
Status:
COMPLETED
Last Update Posted:
2021-10-28
First Post:
2020-03-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-09
First Submit QC Date:
None
Study First Post Date:
2020-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-29
Results First Submit QC Date:
None
Results First Post Date:
2021-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-29
Last Update Post Date:
2021-10-28
Last Update Post Date Type:
ACTUAL